In a filing on Cooper Cos. (NYSE: COO), Stephen Mandel's hedge fund Lone pine Capital disclosed a 5.06%, or 2,435,937 share, stake in the company. The firm did not hold shares at the end of the latest quarter ending March 31, 2012.
The Cooper Companies, Inc. engages in the provision of medical devices for healthcare professionals worldwide. It offers spherical lenses that correct near and farsightedness; toric multifocal lenses, which correct near and farsightedness, as well as address various complex visual defects, such as astigmatism and presbyopia; and aspherical, toric, and multifocal lens products. The company also develops, manufactures, and markets medical devices, diagnostic products, and surgical instruments and accessories that improve healthcare delivery to women in various clinical settings. It markets its products through sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in Pleasanton, California.
The Cooper Companies, Inc. engages in the provision of medical devices for healthcare professionals worldwide. It offers spherical lenses that correct near and farsightedness; toric multifocal lenses, which correct near and farsightedness, as well as address various complex visual defects, such as astigmatism and presbyopia; and aspherical, toric, and multifocal lens products. The company also develops, manufactures, and markets medical devices, diagnostic products, and surgical instruments and accessories that improve healthcare delivery to women in various clinical settings. It markets its products through sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in Pleasanton, California.
Aucun commentaire:
Enregistrer un commentaire